|
Market Closed -
Nasdaq
21:00:00 27/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 33.61 USD | +0.12% |
|
-7.94% | +1.05% |
| 08-24 | Top Midday Decliners | MT |
| 08-24 | Azenta Names Board Member Martin Madaus as Interim CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZENTA, INC. | Other Biotechnology & Medical Research | +0.12% | -7.94% | +1.05% | +11.29% | -60.32% | 1.47B |  | |  |
- Stock Market
- Stocks
- AZTA Stock
- Charts Azenta, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
